AMS R&D

Advanced Medical Solutions (AMS) is a global leader in the development and manufacture of innovative tissue-healing technologies for the surgical and wound care markets. The company's extensive portfolio includes cyanoacrylate-based surgical glues, high-performance sutures, and collagen-based biosurgical devices, alongside advanced wound dressings for chronic and acute care. AMS R&D, the group's dedicated research arm, focuses on advancing core technology platforms such as the Sealantis algae-based sealant and expanding internal surgical applications. Headquartered in the UK, AMS operates a global business model through its own brands like LiquiBand and RESORBA, as well as through strategic OEM partnerships with major healthcare companies. The company is publicly traded on the London Stock Exchange and continues to expand its capabilities through targeted acquisitions and internal innovation.